Advances in newer basal and bolus insulins: impact on type 1 diabetes.
- MedicineCurrent opinion in endocrinology, diabetes, and obesity
The newest basal insulin analogues, insulin glargine U300 and degludec, have proven to be efficient in reducing hypoglycaemic events due to a more stable action profile.
Biomarkers of PTSD: Neuropeptides and immune signaling
- Psychology, MedicineNeuropharmacology
The current evidence including the novel hypothesis that cellular immunity is implicated in PTSD risk and resilience is reviewed, along with evidence for a possible role for CNS inflammation in PTSD symptoms, especially in individuals who have PTSD with co-morbid depression.